Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

March 2013 Onwards
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
27 Feb 2013 - 01 Mar 2013
Sofia, Bulgaria
American Healthcare and Natural Products Expo 2013
04 Mar 2013 - 05 Mar 2013
Rockville, MD, USA
Bioassays 2013: Scientific Approaches & Regulatory Strategies
04 Mar 2013 - 05 Mar 2013
Singapore
Fundamentals of LC/MS
04 Mar 2013 - 05 Mar 2013
Singapore
Mass Spectral Interpretation
25th Annual EuroMeeting 2013
04 Mar 2013 - 06 Mar 2013
RAI, Amsterdam, Netherlands
25th Annual EuroMeeting 2013
11 Mar 2013 - 13 Mar 2013
• Baltimore Hyatt • Baltimore, MD
5th Annual Government Programs Summit
11 Mar 2013 - 15 Mar 2013
San Diego, CA, USA
Medicinal Chemistry 5-Day Program
13 Mar 2013 - 15 Mar 2013
Palais des Congrès, Paris, France
18th Congress of The European Association of Hospital Pharmacists (EAHP)
7th Clinical Billing & Research Compliance
17 Mar 2013 - 20 Mar 2013
KY, USA
7th Clinical Billing & Research Compliance
<< 1 2 3 4 5 6 7 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!